2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II

Abstract

ConclusionOverall, the knowledge level of cervical cancer and its prevention among women was found to be poor. Meanwhile, the screening practice was not high though women have strong intentions to screen. The main obstacles to screening were poverty and insufficient knowledge. Our findings may provide guidance on future education and training to help accelerate the prevention and control of cervical cancer in China.

Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy – an Option or a Must?: A Narrative Review

“…Another multicenter retrospective study reports a 5-year PFS of 70% [60]. In a prospective single center study, LC rate is 73% without grade ≥ 3 late toxicity [47]. With lack of direct comparison between SABR and brachytherapy as the boost modality in Sea-Won Lee, IMRT for Cervical Cancer definitive RT of locally advanced cervical cancer, National Cancer Database data shows inferior survival in patients treated with SABR boost [8].…”